Areas of Specialty:

• Computational aging

• DNA damage

• Clinical trials

Morten Scheibye-Knudsen, PhD

Morten Scheibye-Knudsen is an associate professor at the University of Copenhagen. He combines computational approaches and wet lab science to investigate the molecular basis of aging and to develop interventions allowing us to live longer and healthier lives. He used machine learning to identify mitochondrial changes in premature aging disorders linked to DNA damage and NAD+ loss, suggesting that increasing NAD+ could be therapeutic, a hypothesis he recently lung supported in a clinical trial of COPD patients. In parallel work he has developed algorithms able to predict cellular senescence based on nuclear shapes and linked this predictor to the risk of developing cancer in the future. Outside of his scientific approaches he organizes the yearly ARDD conference; is the CSO of the Healhty Longevity Clinic, acts as a chief editor at Frontiers in Aging; and serves as the president of the Nordic Aging Society.